These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9485309)

  • 1. Glu-320 and Asp-323 are determinants of the CYP4A1 hydroxylation regiospecificity and resistance to inactivation by 1-aminobenzotriazole.
    Dierks EA; Davis SC; Ortiz de Montellano PR
    Biochemistry; 1998 Feb; 37(7):1839-47. PubMed ID: 9485309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of steric bulk and conformational rigidity on fatty acid omega hydroxylation by a cytochrome P450 4A1 fusion protein.
    Bambal RB; Hanzlik RP
    Arch Biochem Biophys; 1996 Oct; 334(1):59-66. PubMed ID: 8837739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical characterization of lauric acid omega-hydroxylation by a CYP4A1/NADPH-cytochrome P450 reductase fusion protein.
    Chaurasia CS; Alterman MA; Lu P; Hanzlik RP
    Arch Biochem Biophys; 1995 Feb; 317(1):161-9. PubMed ID: 7872779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
    Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
    J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygen activation by cytochrome P450BM-3: effects of mutating an active site acidic residue.
    Yeom H; Sligar SG
    Arch Biochem Biophys; 1997 Jan; 337(2):209-16. PubMed ID: 9016815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The catalytic site of cytochrome P4504A11 (CYP4A11) and its L131F mutant.
    Dierks EA; Zhang Z; Johnson EF; de Montellano PR
    J Biol Chem; 1998 Sep; 273(36):23055-61. PubMed ID: 9722531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single mutation in cytochrome P450 BM3 changes substrate orientation in a catalytic intermediate and the regiospecificity of hydroxylation.
    Oliver CF; Modi S; Sutcliffe MJ; Primrose WU; Lian LY; Roberts GC
    Biochemistry; 1997 Feb; 36(7):1567-72. PubMed ID: 9048540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heme-coordinating analogs of lauric acid as inhibitors of fatty acid omega-hydroxylation.
    Lu P; Alterman MA; Chaurasia CS; Bambal RB; Hanzlik RP
    Arch Biochem Biophys; 1997 Jan; 337(1):1-7. PubMed ID: 8990261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of the residue size at position 87 in H2O2- dependent substrate hydroxylation activity and H2O2 inactivation of cytochrome P450BM-3.
    Li QS; Ogawa J; Shimizu S
    Biochem Biophys Res Commun; 2001 Feb; 280(5):1258-61. PubMed ID: 11162663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural determination of the substrate specificities and regioselectivities of the rat and human fatty acid omega-hydroxylases.
    Hoch U; Zhang Z; Kroetz DL; Ortiz de Montellano PR
    Arch Biochem Biophys; 2000 Jan; 373(1):63-71. PubMed ID: 10620324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of rabbit cytochromes P4504A which catalyze the omega-hydroxylation of arachidonic acid, fatty acids, and prostaglandins.
    Roman LJ; Palmer CN; Clark JE; Muerhoff AS; Griffin KJ; Johnson EF; Masters BS
    Arch Biochem Biophys; 1993 Nov; 307(1):57-65. PubMed ID: 8239664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique properties of purified, Escherichia coli-expressed constitutive cytochrome P4504A5.
    Hosny G; Roman LJ; Mostafa MH; Masters BS
    Arch Biochem Biophys; 1999 Jun; 366(2):199-206. PubMed ID: 10356284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylase.
    Glieder A; Farinas ET; Arnold FH
    Nat Biotechnol; 2002 Nov; 20(11):1135-9. PubMed ID: 12368811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-directed mutagenesis of the putative distal helix of peroxygenase cytochrome P450.
    Matsunaga I; Ueda A; Sumimoto T; Ichihara K; Ayata M; Ogura H
    Arch Biochem Biophys; 2001 Oct; 394(1):45-53. PubMed ID: 11566026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kinetic and spectral characterization of the E. coli-expressed mammalian CYP4A7: cytochrome b5 effects vary with substrate.
    Loughran PA; Roman LJ; Miller RT; Masters BS
    Arch Biochem Biophys; 2001 Jan; 385(2):311-21. PubMed ID: 11368012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxygenation of polyunsaturated long chain fatty acids by recombinant CYP4F8 and CYP4F12 and catalytic importance of Tyr-125 and Gly-328 of CYP4F8.
    Stark K; Wongsud B; Burman R; Oliw EH
    Arch Biochem Biophys; 2005 Sep; 441(2):174-81. PubMed ID: 16112640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imidazolyl carboxylic acids as mechanistic probes of flavocytochrome P-450 BM3.
    Noble MA; Quaroni L; Chumanov GD; Turner KL; Chapman SK; Hanzlik RP; Munro AW
    Biochemistry; 1998 Nov; 37(45):15799-807. PubMed ID: 9843385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active site structure and substrate specificity of cytochrome P450 4A1: steric control of ligand approach perpendicular to heme plane.
    Bambal RB; Hanzlik RP
    Biochem Biophys Res Commun; 1996 Feb; 219(2):445-9. PubMed ID: 8605007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of glutamic acid 216 in cytochrome P450 2D6 substrate binding and catalysis.
    Guengerich FP; Hanna IH; Martin MV; Gillam EM
    Biochemistry; 2003 Feb; 42(5):1245-53. PubMed ID: 12564927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual role of human cytochrome P450 3A4 residue Phe-304 in substrate specificity and cooperativity.
    Domanski TL; He YA; Harlow GR; Halpert JR
    J Pharmacol Exp Ther; 2000 May; 293(2):585-91. PubMed ID: 10773032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.